This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Persimmon PLC | 1,258.5 | 4.7% |
| Diageo PLC | 1,768.0 | 3.8% |
| Barratt Redrow PLC | 378.8 | 3.6% |
| Experian PLC | 3,353.0 | 3.5% |
| London Stock Exchange Group PLC | 8,602.0 | 3.3% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Melrose Industries PLC | 570.0 | -6.1% |
| JD Sports Fashion PLC | 72.9 | -5.7% |
| Polar Capital Technology Trust PLC | 433.0 | -5.3% |
| Glencore PLC | 335.0 | -4.0% |
| Rolls-Royce Holdings PLC | 1,038.0 | -3.8% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 9,540 | 0.1% | 15.5% |
| DOW JONES INDUS. AVG | 46,245 | 1.1% | 4.4% |
| DAX INDEX | 23,092 | 0.8% | 19.5% |
| NIKKEI 225 | 48,626 | 2.4% | 25.4% |
| S&P/ASX 200 INDEX | 8,525 | 1.3% | 1.6% |
| Commodity | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 57.93 | 0.22% |
| Brent Crude (ICE) | USD/bbl. | 62.45 | 0.18% |
| Gold Spot | USD/t oz. | 4,063 | 0.1% |
| Copper (Comex) | USd/lb. | 509 | 0.2% |
The UK 100 is called to open +49 points at 9588. The UK 100 index is set to make a robust start to the week after US markets were lifted by a revival of interest rate cut hopes.
The Dow Jones rebounded on Friday after New York Federal Reserve President John Williams suggested the central bank could cut interest rates yet again this year. The blue-chip index gained 493.15 points, or 1.08%, to close at 46,245.41. The Nasdaq advanced 0.88% to settle at 22,273.08, while the S&P finished 0.98% higher at 6,602.99.
Asian markets were mixed today, with Hong Kong’s Hang Seng and South Korea’s KOSPI index closing higher, while the Shanghai Composite remained nearly unchanged. Markets in Japan were closed for a public holiday. Investor sentiment was influenced by the previous week’s volatility on Wall Street, lingering worries over AI-related stocks, and renewed hopes for a potential US rate cut.
AstraZeneca today announced plans to invest $2 billion to expand its manufacturing footprint in the US state of Maryland. This includes significant expansion of its biologics manufacturing facility in Frederick and construction of a new site in Gaithersburg for the development and clinical supply of molecules to be used in clinical trials. The investment, which will support 2,600 jobs across the two sites, is part of AstraZeneca’s $50 billion investment announced in July and follows a series of US commitments over the past six months. It is also planning a new cell therapy manufacturing facility in Rockville, Maryland, a new drug substance manufacturing facility in Virginia and the expansion of the company’s existing manufacturing facility in Coppell, Texas. The US is AstraZeneca’s largest market by sales and is also home to 19 R&D, manufacturing and commercial sites. The company’s US workforce exceeds more than 25,000 people.
BHP today said it is no longer considering a takeover move for FTSE 100-listed Anglo American. BHP, which failed with a bid for Anglo American in 2024, reopened its interest whilst Anglo prepares to complete a merger with Canada’s Teck Resources. BHP said: “Following preliminary discussions with the board of Anglo American, BHP confirms that it is no longer considering a combination of the two companies.
UK
US
Zoom Communications Inc (ZM) AMC
UK
Compass Group (CPG)
Marstons (MARS)
AO World (AO.)
Cranswick (CWK)
EasyJet (EZJ)
US
Alibaba Group Holding Ltd ADR (BABA) PMO
NIO Inc ADR (NIO) PMO
Cleanspark Inc (CLSK) AMC
HP Inc (HPQ) AMC
Zscaler Inc (ZS) AMC
German IFO
ECB’s Cipollone speech
ECB’s Elderson speech
ECB’s President Lagarde speech
ECB’s Nagel speech
UK 100 companies going ex-dividend on 27th November 2025:
Imperial Brands
Alliance Whitan
Marks and Spencer Group
International Consolidated Airlines Group
3i Group
Land Securities Group
Severn Trent
LondonMetric Property
UK 250 companies going ex-dividend on 27th November 2025:
Hill & Smith
Oxford Instruments
FirstGroup
HICL Infrastructure
Ithaca Energy
Great Portland Estates
Johnson Matthey
PayPoint
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.